Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Expres2ion Biotech holding AB (EXPRS2) NPV

Sell:4.45 SEK Buy:4.57 SEK Change: 0.02 SEK (0.43%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:4.45 SEK
Buy:4.57 SEK
Change: 0.02 SEK (0.43%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:4.45 SEK
Buy:4.57 SEK
Change: 0.02 SEK (0.43%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ExpreS2ion Biotech Holding AB is a Sweden-based biopharmaceutical company. The Company specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The Company's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. It also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.

Contact details

Address:
Terminalgatan 1
HELSINGBORG
252 78
Sweden
Telephone:
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EXPRS2
ISIN:
SE0008348262
Market cap:
62.57 million SEK
Shares in issue:
13.60 million
Sector:
Biotechnology
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Martin Jensen
    Chairman of the Board
  • Bent Frandsen
    Chief Executive Officer
  • Charlotte Dyring
    Chief Operating Officer
  • Willem de Jongh
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.